First Missense Mutation in the SOST Gene Causing Sclerosteosis by Loss of Sclerostin Function

被引:63
|
作者
Piters, Elke [1 ]
Culha, Cavit [2 ]
Moester, Martiene [3 ]
Van Bezooijen, Rutger [3 ]
Adriaensen, Dirk [4 ]
Mueller, Thomas [5 ]
Weidauer, Stella [5 ]
Jennes, Karen [1 ]
De Freitas, Fenna [1 ]
Lowik, Clemens [3 ]
Timmermans, Jean-Pierre [4 ]
Van Hul, Wim [1 ]
Papapoulos, Socrates [3 ]
机构
[1] Univ Antwerp, Dept Med Genet, B-2650 Edegem, Belgium
[2] Ankara Numune Training & Res Hosp, Dept Endocrinol & Metab, Ankara, Turkey
[3] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands
[4] Univ Antwerp, Lab Cell Biol & Histol, B-2650 Edegem, Belgium
[5] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, D-97070 Wurzburg, Germany
关键词
SOST; sclerostin; Wnt signaling; sclerosteosis; VAN-BUCHEM-DISEASE; DISULFIDE BOND FORMATION; ENDOPLASMIC-RETICULUM; CHROMOSOME; 17Q12-Q21; MINERAL DENSITY; LRP5; MUTATIONS; BMP ANTAGONIST; HUMAN LYSOZYME; SECRETION; PROTEIN;
D O I
10.1002/humu.21274
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Sclerosteosis is a rare bone dysplasia characterized by greatly increased bone mass, especially of the long bones and the skull. Patients are tall, show facial asymmetry and often have syndactyly. Clinical complications are due to entrapment of cranial nerves. The disease is thought to be due to loss-of-function mutations in the SOST gene. The SOST gene product, sclerostin, is secreted by osteocytes and transported to the bone surface where it inhibits osteoblastic bone formation by antagonizing Wnt signaling. In a small Turkish family with sclerosteosis, we identified a missense mutation (c.499T>C; p.Cys167Arg) in exon 2 of the SOST gene. This type of mutation has not been previously reported and using different functional approaches, we show that it has a devastating effect on the biological function of sclerostin. The affected cysteine is the last cysteine residue of the cystine-knot motif and loss of this residue leads to retention of the mutant protein in the ER, possibly as a consequence of impaired folding. Together with a significant reduced ability to bind to LRP5 and inhibit Wnt signaling, the p.Cys167Arg mutation leads to a complete loss of function of sclerostin and thus to the characteristic sclerosteosis phenotype. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:E1526 / E1543
页数:18
相关论文
共 50 条
  • [41] A novel gene insertion combined with a missense mutation causing factor VII deficiency in two unrelated Chinese families
    Hao, Xiuping
    Cheng, XiaoLi
    Wang, Yingyu
    Yang, LiHong
    Xie, Yaosheng
    Wang, Mingshan
    Jin, Yanhui
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (06) : 687 - 690
  • [42] Novel loss of function mutation in TUBA1A gene compromises tubulin stability and proteostasis causing spastic paraplegia and ataxia
    Zocchi, Riccardo
    Bellacchio, Emanuele
    Piccione, Michela
    Scardigli, Raffaella
    D'Oria, Valentina
    Petrini, Stefania
    Baranano, Kristin
    Bertini, Enrico
    Sferra, Antonella
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2023, 17
  • [43] Loss-of-function epigenetic mutation of BONSAI gene in Arabidopsis
    Saze, Hidetoshi
    Kakutani, Tetsuji
    GENES & GENETIC SYSTEMS, 2006, 81 (06) : 457 - 457
  • [44] First description of phosphofructokinase deficiency in spain: identification of a novel homozygous missense mutation in the PFKM gene
    Vives-Corrons, Joan-Lluis
    Koralkova, Pavla
    Grau, Josep M.
    Manu Pereira, Maria del Mar
    Van Wijk, Richard
    FRONTIERS IN PHYSIOLOGY, 2013, 4
  • [45] Expanding the mutation spectrum of Caveolinopathies: a novel heterozygous missense mutation in CAV3 gene causing idiopathic persistent hyperCKemia and dyslipidemia.
    Bruno, G.
    Oliva, M.
    Allegorico, L.
    Sampaolo, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 170 - 171
  • [46] Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement
    Oguchi, K
    Takagi, M
    Tsuchida, R
    Taya, Y
    Ito, E
    Isoyama, K
    Ishii, E
    Zannini, L
    Delia, D
    Mizutani, S
    BLOOD, 2003, 101 (09) : 3622 - 3627
  • [47] Loss-of-function EHMT2 missense mutation as the cause of a Kleefstra-like syndrome
    Martinez-Delgado, Beatriz
    Lopez-Martin, Estrella
    Kerkhof, Jennifer
    Baladron, Beatriz
    Mielu, Lidia
    Sanchez-Ponce, Diana
    Bada-Navarro, Ariadna
    Herrero-Matesanz, Marina
    Lopez, Lidia
    Rzasa, Jessica
    Rots, Dmitrijs
    Fernandez Prieto, Marta
    Hernandez-San Miguel, Esther
    Gomez-Mariano, Gema
    Marin Reina, Purificacion
    Cazorla-Calleja, Rosario
    Javier Alonso, Francisco
    Kleefstra, Tjitske
    Posada, Manuel
    Bermejo-Sanchez, Eva
    Sadikovic, Bekim
    Barrero, Maria J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1750 - 1750
  • [48] The Opdc missense mutation of Pax2 has a milder than loss-of-function phenotype
    Cross, Sally H.
    McKie, Lisa
    West, Katrine
    Coghill, Emma L.
    Favor, Jack
    Bhattacharya, Shoumo
    Brown, Steve D. M.
    Jackson, Ian J.
    HUMAN MOLECULAR GENETICS, 2011, 20 (02) : 223 - 234
  • [49] A novel missense mutation D676N in the plasminogen gene causes loss of functional activity
    Yamaguchi, M
    Sugiyama, S
    Noda, H
    Tatsumi, S
    Yoshimura, M
    HUMAN HEREDITY, 1997, 47 (04) : 234 - 236
  • [50] NOVEL MISSENSE MUTATION IN THE PHENYLALANINE-HYDROXYLASE GENE LEADING TO COMPLETE LOSS OF ENZYMATIC-ACTIVITY
    DIANZANI, I
    KNAPPSKOG, PM
    DESANCTIS, L
    GIANNATTASIO, S
    RIVA, E
    PONZONE, A
    APOLD, J
    CAMASCHELLA, C
    HUMAN MUTATION, 1995, 6 (03) : 247 - 249